GALECTIN THERAPEUTICS INC. Preferred Stock Dividends and Other Adjustments
GALECTIN THERAPEUTICS INC. (GALT) reported Preferred Stock Dividends and Other Adjustments of $62.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2026-08-14
- GALECTIN THERAPEUTICS INC. preferred stock dividends and other adjustments for the quarter ending 2026-06-30 was $62.00K, a 1.59% decline year-over-year.
- GALECTIN THERAPEUTICS INC. preferred stock dividends and other adjustments for the quarter ending 2026-03-31 was $21.00K.
- GALECTIN THERAPEUTICS INC. preferred stock dividends and other adjustments for the quarter ending 2025-12-31 was $62.00K, a 1.59% decline year-over-year.
- GALECTIN THERAPEUTICS INC. preferred stock dividends and other adjustments for the quarter ending 2025-09-30 was $39.00K, a 116.67% increase year-over-year.
- GALECTIN THERAPEUTICS INC. preferred stock dividends and other adjustments for fiscal 2025 was $138.00K, a 9.80% decline from fiscal 2024.
- GALECTIN THERAPEUTICS INC. preferred stock dividends and other adjustments for fiscal 2024 was $153.00K, a 27.50% increase from fiscal 2023.
- GALECTIN THERAPEUTICS INC. preferred stock dividends and other adjustments for fiscal 2023 was $120.00K, a 23.71% increase from fiscal 2022.
- GALECTIN THERAPEUTICS INC. preferred stock dividends and other adjustments for fiscal 2022 was $97.00K.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 9 month | Preferred Stock Dividends and Other Adjustments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $62.00K 10-Q · filed 2026-08-14 | $83.00K 10-Q · filed 2026-08-14 | $145.00K derived: sum of 3 quarters · filed 2026-08-14 | $184.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $21.00K 10-Q · filed 2026-05-15 | $83.00K derived: sum of 2 quarters · filed 2026-05-15 | $122.00K derived: sum of 3 quarters · filed 2026-05-15 | $185.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $101.00K derived: sum of 2 quarters · filed 2026-03-31 | $164.00K derived: sum of 3 quarters · filed 2026-08-14 | $138.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $39.00K 10-Q · filed 2025-11-14 | $102.00K derived: sum of 2 quarters · filed 2026-08-14 | $76.00K 10-Q · filed 2025-11-14 | $139.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $63.00K 10-Q · filed 2026-08-14 | $37.00K 10-Q · filed 2026-08-14 | $100.00K derived: sum of 3 quarters · filed 2026-08-14 | $118.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$26.00K 10-Q · filed 2026-05-15 | $37.00K derived: sum of 2 quarters · filed 2026-05-15 | $55.00K derived: sum of 3 quarters · filed 2026-05-15 | $119.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $81.00K derived: sum of 2 quarters · filed 2026-03-31 | $145.00K derived: sum of 3 quarters · filed 2026-03-31 | $153.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $18.00K 10-Q · filed 2025-11-14 | $82.00K derived: sum of 2 quarters · filed 2025-11-14 | $90.00K 10-Q · filed 2025-11-14 | $153.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $64.00K 10-Q · filed 2025-08-14 | $72.00K 10-Q · filed 2025-08-14 | $135.00K derived: sum of 3 quarters · filed 2025-08-14 | $129.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $8.00K 10-Q · filed 2025-05-15 | $71.00K derived: sum of 2 quarters · filed 2025-05-15 | $65.00K derived: sum of 3 quarters · filed 2025-05-15 | $128.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $57.00K derived: sum of 2 quarters · filed 2025-03-31 | $120.00K derived: sum of 3 quarters · filed 2025-03-31 | $120.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$6.00K 10-Q · filed 2024-11-14 | $57.00K derived: sum of 2 quarters · filed 2024-11-14 | $57.00K 10-Q · filed 2024-11-14 | $122.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $63.00K 10-Q · filed 2024-08-13 | $63.00K 10-Q · filed 2024-08-13 | $128.00K derived: sum of 3 quarters · filed 2024-08-13 | $112.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | $65.00K derived: sum of 2 quarters · filed 2024-05-15 | $49.00K derived: sum of 3 quarters · filed 2024-05-15 | $113.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $49.00K derived: sum of 2 quarters · filed 2024-03-29 | $113.00K derived: sum of 3 quarters · filed 2024-03-29 | $97.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | -$16.00K 10-Q · filed 2023-11-13 | $48.00K derived: sum of 2 quarters · filed 2023-11-13 | $32.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $64.00K 10-Q · filed 2023-08-14 | $48.00K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$16.00K 10-Q · filed 2023-05-15 | |||
| 2021-09-30 | $37.00K 10-Q · filed 2022-11-14 | $102.00K derived: sum of 2 quarters · filed 2022-11-14 | $104.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $65.00K 10-Q · filed 2022-08-15 | $67.00K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |